Beth Israel Deaconess Medical Center in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital.
There are 673 beds in Beth Israel Deaconess Medical Center.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Beth Israel Deaconess Medical Center
387
Dana-Farber Cancer Institute
183
Massachusetts General Hospital
101
National Cancer Institute (NCI)
96
National Institute of Allergy and Infectious Diseases (NIAID)
68
Gilead Sciences
42
Bristol-Myers Squibb
41
Eastern Cooperative Oncology Group
36
Pfizer
31
Hoffmann-La Roche
27
Boston Scientific Corporation
25
Clinical Trials at Beth Israel Deaconess Medical Center
During the past decade, Beth Israel Deaconess Medical Center conducted 838 clinical trials. In the 10-year time frame, 838 clinical trials started and 572 clinical trials were completed, i.e. on
average, 68.3% percent of trials that started reached the finish line to date. In the past 5 years, 285 clinical trials started and 233 clinical trials were completed. i.e. 81.8%
of trials that started reached the finish line.
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
1993-11-01
Completed
500
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center" #1 sponsor was "Beth Israel Deaconess Medical Center" with 387 trials, followed by "Dana-Farber Cancer Institute" with 183 trials
sponsored, "Massachusetts General Hospital" with 101 trials sponsored, "National Cancer Institute (NCI)" with 96 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)"
with 96 trials sponsored. Other sponsors include 1183 different institutions and
companies that sponsored additional 555 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center"
#1 collaborator was "Beth Israel Deaconess Medical Center" with 196 trials as a collaborator, "National Cancer Institute (NCI)" with 165 trials as a collaborator, "Brigham and Women's Hospital" with 122 trials as a collaborator, "Massachusetts General Hospital" with 96 trials as a collaborator and "Dana-Farber Cancer Institute" with 59 trials as a collaborator. Other collaborators include 1784 different institutions and companies that were
collaborators in the rest 696 trials.
Clinical Trials Conditions at Beth Israel Deaconess Medical Center
According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Medical Center" are
"Breast Cancer" (95 trials), "HIV Infections" (94 trials), "Prostate Cancer" (57 trials), "Multiple Myeloma" (47 trials) and "Lung Cancer" (32 trials). Many other conditions were trialed in "Beth Israel Deaconess Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Beth Israel Deaconess Medical Center
Most popular intervention types in "Beth Israel Deaconess Medical Center" are "Drug" (1276 trials), "Other" (272 trials), "Biological" (250 trials), "Device" (243 trials) and "Procedure" (148 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (197 trials), "Nivolumab" (54 trials), "Laboratory Biomarker Analysis" (51 trials), "Bevacizumab" (43 trials) and "Paclitaxel" (35 trials). Other intervention names were less common.
Clinical Trials Genders at Beth Israel Deaconess Medical Center
The vast majority of trials in "Beth Israel Deaconess Medical Center" are
1796 trials for "All" genders, 148 trials for "Female" genders and 79 trials for "Male" genders.
Clinical Trials Status at Beth Israel Deaconess Medical Center
Currently, there are 567 active trials in "Beth Israel Deaconess Medical Center".
8 are not yet recruiting,
271 are recruiting,
281 are Active, not recruiting,
and 7 are Enrolling by invitation.
In total, there were 1129 completed trials in Beth Israel Deaconess Medical Center,
9 suspended trials,
and 211 terminated clinical trials to date.
Out of the total trials that were conducted in Beth Israel Deaconess Medical Center, 334 "Phase 1"
clinical trials were conducted, 778 "Phase 2" clinical
trials and 395 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 53 trials, and there were
also 387 trials that are defined as “Not Applicable".
Departments of Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center has several departments that took part in Clinical trials: "Beth Israel Deaconess Med Ctr; Hem/Onc" - 4 trials, "Beth Israel Comprehensive Cancer Center" - 4 trials, "Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine" - 3 trials, "Beth Israel Deaconess Med Ctr; Neurology/MS Center" - 3 trials, "Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center" - 3 trials, "Beth Israel Deaconess Medical Center/ Massachusetts Mental Health Center" - 2 trials, "Pain Clinic at Beth Israel Deaconess Medical Center" - 2 trials, "Douglas Plesko" - 2 trials